Metraipolis › archive › dc_7434ddaf7bc1

Per-patient Comparison of [68Ga]-FAPI-46 Versus [18F]FDG as PET Tracers in ER-positive Breast Cancer: Study Design of a Single-centre Prospective Study — Europe PMC PMID:42807247

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42807247
DOI
10.7150/jca.138448
License (as archived)
solo-consultazione
Archived
2026-10-08T06:54:01.576Z
SHA-256 of the archived text
ba129e8043519148bec3dd588dd02d8f9d13475607434dc40b3963875af0b266
Stable URL of this page
https://metraipolis.com/documento/dc_7434ddaf7bc1

How to cite

Per-patient Comparison of [68Ga]-FAPI-46 Versus [18F]FDG as PET Tracers in ER-positive Breast Cancer: Study Design of a Single-centre Prospective Study — Europe PMC PMID:42807247 — Europe PMC (en), https://europepmc.org/article/MED/42807247 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7434ddaf7bc1 (Metraipolis archive dc_7434ddaf7bc1, sha256 ba129e8043519148bec3dd588dd02d8f9d13475607434dc40b3963875af0b266)
BibTeX
@misc{dc7434ddaf7bc1,
  title = {Per-patient Comparison of [68Ga]-FAPI-46 Versus [18F]FDG as PET Tracers in ER-positive Breast Cancer: Study Design of a Single-centre Prospective Study — Europe PMC PMID:42807247},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42807247},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7434ddaf7bc1; sha256 ba129e8043519148bec3dd588dd02d8f9d13475607434dc40b3963875af0b266},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42807247. Agents can read the archived copy with the MCP tool read_document.